Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Menopause. 2019 Aug;26(8):816–822. doi: 10.1097/GME.0000000000001341

Table 3.

Proportion of women reporting sexual activity at week 12 by intervention arm. Report of sexual activity in the past month was obtained from week 12 visit questionnaires, while report of sexual activity or penetrative sex in the past week was from participant diaries for the week prior to the final study visit.

Difference
Vaginal estradiol + placebo gel Vaginal moisturizer + placebo tablet Dual placebo Estradiol vs. Placebo Moisturizer vs. placebo

Outcome N Percent (95% CI) N Percent (95% CI) N Percent (95% CI) OR a p value OR a p value
Sexual activity in the past month 99 77.8 (69.4, 86.1) 99 86.9 (80.1, 93.6) 94 84.0 (76.5, 91.6) 0.8 (0.4, 1.7) 0.52 1.5 (0.6, 3.7) 0.34

Sexual activity in the past week 93 49.5 (39.1, 59.8) 91 35.2 (25.2, 45.2) 93 39.8 (29.7, 49.9) 1.7 (0.9, 3.1) 0.10 0.8 (0.5, 1.6) 0.59

Penetrative sex in the past week 92 43.5 (33.2, 53.8) 91 33.0 (23.1, 42.8) 92 34.8 (24.9, 44.7) 1.6 (0.9, 3.0) 0.12 1.0 (0.5, 1.8) 0.91
a

Odds ratio and p-value from a logistic regression model with week 12 outcome as a function of intervention arm, clinical site, and reported sexual activity in the past month at baseline (yes/no)